CytomX Therapeutics, Inc. (FRA:6C1)

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $5.96M USD in the quarter ending September 30, 2025, a decrease of -82.16%. This brings the company's revenue in the last twelve months to $113.63M, down -10.26% year-over-year. In the year 2024, CytomX Therapeutics had annual revenue of $138.10M with 36.45% growth.

• Revenue (ttm): $113.63M
• Revenue Growth: -10.26%
• P/S Ratio: 6.46
• Revenue / Employee: $939.10K
• Employees: 121
• Market Cap: 625.26M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.10M	36.89M	36.45%
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%
Dec 31, 2019	26.90M	-32.60M	-54.79%
Dec 31, 2018	59.50M	-12.12M	-16.92%
Dec 31, 2017	71.62M	56.58M	376.12%
Dec 31, 2016	15.04M	7.33M	95.06%
Dec 31, 2015	7.71M	2.64M	51.90%
Dec 31, 2014	5.08M	4.19M	471.73%
Dec 31, 2013	888.00K	-	-